One-Year Outcomes of Photodynamic Therapy in Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy in Japanese Patients-Reference-Cited by-同舟云学术

One-Year Outcomes of Photodynamic Therapy in Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy in Japanese Patients

Published:2008-01 Issue:1 Volume:115 Page:141-146
ISSN:0161-6420
Container-title:Ophthalmology
language:en
Short-container-title:Ophthalmology

Author:

Gomi Fumi,Ohji Masahito,Sayanagi Kaori,Sawa Miki,Sakaguchi Hirokazu,Oshima Yusuke,Ikuno Yasushi,Tano Yasuo

Publisher

Elsevier BV

Subject

Ophthalmology

Reference23 articles.

1. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials—TAP report 1;Arch Ophthalmol,1999

2. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials—TAP report 2;Arch Ophthalmol,2001

3. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: additional information regarding baseline lesion composition’s impact on vision outcomes—TAP report no.3;Arch Ophthalmol,2002

4. Japanese Age-Related Macular Degeneration Trial: 1-year results of photodynamic therapy with verteporfin in Japanese patients with subfoveal choroidal neovascularization secondary to age-related macular degeneration;Am J Ophthalmol,2003

5. Polypoidal choroidal vasculopathy;Ciardella;Surv Ophthalmol,2004

Cited by 226 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anti-VEGF Treatment Strategies for 3 Subtypes of Neovascular Age-Related Macular Degeneration in a Clinical Setting;Ophthalmology Retina;2023-10

2. Long-Term Prognosis of Patients with Polypoidal Choroidal Vasculopathy Treated with Photodynamic Therapy;Journal of Clinical Medicine;2023-07-16

3. Current Management of Subretinal Hemorrhage in Neovascular Age-Related Macular Degeneration;Ophthalmologica;2023

4. Clinical features and outcomes of breakthrough vitreous hemorrhage secondary to polypoidal choroidal vasculopathy;PLOS ONE;2022-12-30

5. To compare the short-term efficacy and safety of combination therapy with standard fluence and reduced fluence PDT in polypoidal choroidal vasculopathy;Indian Journal of Clinical and Experimental Ophthalmology;2022-12-15